Chronic Granulomatous Disease Plasma | High-Quality Human Plasma from Chronic Granulomatous Disease Donors

Chronic Granulomatous Disease Plasma is collected from donors clinically diagnosed with Chronic Granulomatous Disease (CGD) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in chronic granulomatous disease pathophysiology.

Product Features

• Research Use Only (RUO)
• Plasma collected from clinically confirmed CGD donors
• Processed within one day of collection
• IRB-approved protocols and informed consent
• Custom aliquot volumes available upon request

Donor Metadata

• Verified CGD diagnosis
• Demographic data: age, sex assigned at birth, race/ethnicity
• Donor-reported medications, allergies, and comorbidities
• Additional chronic granulomatous disease-specific metadata available

Applications

• Biomarker discovery and validation
• Cytokine and inflammation profiling
• Metabolomics and proteomics studies
• Therapeutic response research

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Chronic Granulomatous Disease plasma is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.